Researchers Show Human Heart Muscle Cells Can Regrow After Heart Attack

The human heart does possess a hidden biological mechanism to regrow muscle cells after a heart attack, overturning decades of medical consensus that cardiac tissue is permanently incapable of regeneration. While this natural repair response is currently too weak to heal the organ on its own, researchers have now proven that adult heart cells can re-enter the division cycle following severe ischemic injury. The findings provide the foundational evidence required to pursue therapies that could one day reverse the damage caused by cardiovascular disease.[1][2][3][4]

Clinical cardiology has long operated on the assumption that a myocardial infarction—which can destroy up to one-third of the heart's muscle cells—leaves behind permanent, irreversible scar tissue. Previous anatomical studies, including baseline measurements taken from 52 patients with advanced heart failure, suggested that human cardiomyocytes largely cease producing daughter cells around 20 years of age. In a healthy adult, the heart maintains an annual cellular renewal rate of just 0.5 percent. Because the organ's fractional renewal rate is vastly outpaced by the massive cell death of a heart attack, the resulting scar tissue permanently reduces the heart's ability to pump blood.[1][2][4]

However, the landmark study, initially published online in late 2025 and highlighted across medical platforms in September 2026, provides the first direct evidence that the human heart actively attempts to repair itself. While research in murine models had previously shown that rodent hearts could increase cell division after an ischemic event, the lack of human evidence had stalled clinical progress. By analyzing living heart tissue collected from patients undergoing coronary artery bypass surgery at Sydney's Royal Prince Alfred Hospital, the research team observed a measurable increase in mitosis within the damaged areas.[1][2][3][4]

To map this cellular response, the researchers collected tissue samples from the infarct border zone—the area immediately surrounding the dead tissue—and from remote, healthier zones approximately 7 to 14 days after the patients suffered a heart attack. They utilized a novel post-infarction biopsy method alongside single-nucleus RNA sequencing on a dataset containing 191,795 nuclei. This multi-omics approach, which also included proteomics and metabolomics, allowed the team to characterize the specific ischemic environment that promotes intrinsic cell division.[2][4]

Within the border zone samples, the team found direct visual and genetic evidence of cell division. Crucially, they identified two cardiomyocytes caught in late cytokinesis—the final stage of mitosis where a cell physically separates into two distinct daughter cells. This confirmed that the adult human heart cells were not merely replicating their DNA in a failed attempt to divide, but were successfully multiplying in response to the injury.[4][5]

"Until now we've thought that, because heart cells die after a heart attack, those areas of the heart were irreparably damaged, leaving the heart less able to pump blood to the body's organs," said Dr. Robert Hume, the study's first author and a researcher at the University of Sydney and the Baird Institute. "Our research shows that while the heart is left scarred after a heart attack, it produces new muscle cells, which opens up new possibilities."[1]

Despite the biological breakthrough, the researchers are careful to manage clinical expectations. The natural regenerative response is far too weak to replace the massive volume of cells lost during a major infarction. The heart still forms debilitating scar tissue, and the limited mitosis observed in the study is not sufficient to prevent the onset of heart failure on its own. The immediate clinical reality for patients remains unchanged, requiring standard interventions to manage the damage.[1][2][3][5]

"Although this new discovery of regrowing muscle cells is exciting, it isn't enough to prevent the devastating effects of a heart attack," Hume cautioned. Because the intrinsic repair mechanism cannot independently heal the organ, physicians must continue to rely on established treatments like stents, bypass surgery, and medications to preserve whatever heart function remains.[1][5]

The true value of the discovery lies in its potential as a therapeutic blueprint. By identifying the specific RNA transcripts, proteins, and metabolites that trigger this mitotic response in humans, scientists now have a biological target. "In time, we hope to develop therapies that can amplify the heart's natural ability to produce new cells and regenerate the heart after an attack," Hume noted, pointing toward future drugs that could artificially boost this repair switch.[1][4]

If researchers can successfully develop targeted therapies to safely enhance this natural repair process, it could fundamentally alter the trajectory of cardiovascular medicine. Rather than simply managing the decline of a scarred organ, the next generation of treatments could focus on active regeneration. The identification of the heart's intrinsic mitotic potential provides the exact biological foundation needed to pursue treatments that could one day reverse heart failure entirely.[3][4][5]